APN401
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for APN401, covering 2018-07-03 to 2024-10-10. Get the full timeline:
Most recent: Clinical Trial Update: APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery [Phase 1]